![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0277.jpg)
Heterogeneity
•
The results loose credibility
•
Different effect sizes in different trials
•
Different patient cohorts?
•
Different treatment efficacy?
•
Quality of data
- How often is the TSH measured?
- In Hodgkin patients?
- In H&NSCC patients?
•
An opportunity to learn
•
Which patients benefit?
•
Which is the better treatment?
The assumption behind a meta-analysis is that
1) The interventio i t same
2) The effect size is the same in different cohorts